NYSE:PEN
Penumbra Inc Stock News
$203.53
+2.00 (+0.99%)
At Close: May 17, 2024
Penumbra (PEN) Launches New Technology for Blood Clot Removal
08:48am, Wednesday, 07'th Jun 2023
Penumbra (PEN) launches Lightning Bolt 7, a new technology that can remove blood clots faster and more efficiently with modulated aspiration.
7 High-Flying Stocks Destined to Crash Back to Earth
08:53pm, Wednesday, 31'st May 2023
Before diving into the discussion of overvalued stocks due for correction, we need to establish one thing about this list: every company you see here represents a fundamentally sound business. In othe
Buy These 4 Low-Beta Stocks to Sail Through Market Volatility
07:34am, Monday, 22'nd May 2023
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Penumbra (PEN), Lamb Weston (LW), Transportadora (TGS) and AeroVironment (AVAV) are poised to gain.
Buy These 4 Low-Beta Stocks to Endure Market Volatility
09:09am, Friday, 05'th May 2023
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Penumbra (PEN), Lamb Weston (LW), Transportadora (TGS) and Novo Nordisk (NVO) are poised to gain.
Penumbra, Inc. (PEN) Q1 2023 Earnings Call Transcript
11:59pm, Tuesday, 02'nd May 2023
Penumbra, Inc. (NYSE:PEN ) Q1 2023 Earnings Conference Call May 2, 2023 4:30 PM ET Company Participants Jee Hamlyn-Harris - Investor Relations Adam Elsesser - Chairman & Chief Executive Officer Maggie
Penumbra (PEN) Surpasses Q1 Earnings and Revenue Estimates
07:09pm, Tuesday, 02'nd May 2023
Penumbra (PEN) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to loss of $0.01 per share a year ago.
Penumbra: Deep Dive Answering Key Investment Questions
06:35am, Friday, 07'th Apr 2023
Penumbra has demonstrated its capacity to unlock long-term shareholder value. After a lumpy performance in FY'22, shares have since re-rated more than 100% higher off lows.
Should iShares Morningstar Small-Cap ETF (ISCB) Be on Your Investing Radar?
10:20am, Monday, 03'rd Apr 2023 Zacks Investment Research
Style Box ETF report for ISCB
Investment in procedural medical devices is safer for valuation, says E Squared's Les Funtleyder
02:12pm, Thursday, 30'th Mar 2023
Les Funtleyder, portfolio manager for E Squared Capital Management, joins 'The Exchange' to discuss big cap pharma's Q1 performance, the dollar weakness contributing to biotech gains, and investment o
Where Penumbra Stands With Analysts
04:00pm, Wednesday, 29'th Mar 2023 Benzinga
Analysts have provided the following ratings for Penumbra (NYSE:PEN) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
5
2
0
0
0
Last 30D
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
03:00pm, Wednesday, 29'th Mar 2023 Benzinga
Upgrades
According to Sidoti & Co., the prior rating for Federal Agricultural Mortgage Corp (NYSE:AGM) was changed from Neutral to Buy. In the fourth quarter, Federal Agricultural showed an EPS of $3.
Should iShares Morningstar Small-Cap Growth ETF (ISCG) Be on Your Investing Radar?
10:20am, Monday, 13'th Mar 2023 Zacks Investment Research
Style Box ETF report for ISCG
Are These Medical Device Makers Getting Ready To Rally?
06:56am, Friday, 10'th Mar 2023
Large-cap medical device maker Stryker Corp. (NYSE: SYK) is consolidating along its 50-day moving average, a bullish sign as the stock takes a breather after a run-up that began last year.
Why Penumbra CEO Adam Elsesser Says It's Going To Be 'The Most Extraordinary Year'
08:00am, Wednesday, 08'th Mar 2023
It's going to be "the most extraordinary year," says Penumbra CEO Adam Elsesser — and PEN stock is showing evidence of that enthusiasm. The post Why Penumbra CEO Adam Elsesser Says It's Going To Be
Insiders Selling Moderna, Hayward Holdings And 2 Other Stocks
02:14pm, Monday, 06'th Mar 2023 Benzinga
The Nasdaq Composite gained more than 200 points on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it indicates their concern in the company’s prosp